Antimicrobial effects of murine mesenchymal stromal cells directed against Toxoplasma gondii and Neospora caninum: Role of immunity-related GTPases (IRGs) and guanylate-binding proteins (GBPs)

Medical Microbiology and Immunology

Volumn 202, Issue 3, 2013, Pages 197-206

  Spekker, K ^a   Leineweber, M ^a   Degrandi, D ^a   Ince, V ^a   Brunder, S ^a   Schmidt, S K ^a   Stuhlsatz, S ^a   Howard, J C ^b   Schares, G ^c   Degistirici, O ^a   Meisel, R ^a   Sorg, R V ^a   Seissler, J ^d   Hemphill, A ^e   Pfeffer, K ^a   Daubener W ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b UNIVERSITY OF COLOGNE   (Germany)

^c FEDERAL RESEARCH INSTITUTE FOR ANIMAL HEALTH   (Germany)

^d LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^e UNIVERSITY OF BERN   (Switzerland)

Author keywords

GBPs; IIRGs; Interferon gamma; Mesenchymal stem cells; Neospora caninum; Toxoplasma gondii

Indexed keywords

GAMMA INTERFERON; GUANINE NUCLEOTIDE BINDING PROTEIN; GUANOSINE TRIPHOSPHATASE; GUANYLATE BINDING PROTEIN 1; GUANYLATE BINDING PROTEIN 2; PROTEIN IRGA6; PROTEIN IRGB6; PROTEIN IRGD; REGULATOR PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL ACTIVATION; CELL FUNCTION; CONTROLLED STUDY; DEFENSE MECHANISM; GROWTH INHIBITION; HOST PARASITE INTERACTION; MESENCHYMAL STROMA CELL; MOUSE; NEOSPORA CANINUM; NONHUMAN; PARASITOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; STRAIN DIFFERENCE; TOXOPLASMA GONDII;

ANIMALS; GTP PHOSPHOHYDROLASES; GTP-BINDING PROTEINS; INTERFERON-GAMMA; MESENCHYMAL STROMAL CELLS; MICE; NEOSPORA; TOXOPLASMA;

EID: 84879094321     PISSN: 03008584     EISSN: 14321831     Source Type: Journal    
DOI: 10.1007/s00430-012-0281-y     Document Type: Article

References (38)

1. Caplan A (2007) Adult mesenchymal stem cells for tissue engineering versus regenerative medicine. J Cell Physiol 213:341-347
2. Shi M, Liu ZW, Wang FS (2011) Immunomodulatory properties and therapeutic application of mesenchymal stem cells. Clin Exp Immunol 164:1-8
3. Meisel R, Zibert A, Laryea M, Göbel U, Däubener W, Dilloo D (2004) Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase-mediated tryptophan degradation. Blood 103:4619-4621
4. Shi Y, Hu G, Su J, Li W, Chen Q, Shou P, Xu C, Chen X, Huang Y, Zhu Z, Huang X, Han S, Xie N, Ren G (2010) Mesenchymal stem cells: a new strategy for immunosuppression and tissue repair. Cell Res 20:510-518
5. Sattler C, Steinsdoerfer M, Offers M, Fischer E, Schierl R, Heseler K, Däubener W, Seissler J (2011) Inhibition of T-cell proliferation by murine multipotent mesenchymal stromal cells is mediated by CD39 expression and adenosine generation. Cell Transplant 20:1221-1230
6. Lanz TV, Opitz CA, Ho PP, Agrawal A, Lutz C, Weller M, Mellor AL, Steinman L, Wick W, Platten M (2010) Mouse mesenchymal stem cells suppress antigen-specific TH cell immunity independent of indoleamine 2,3-dioxygenase 1 (IDO1). Stem Cells Dev 19:657-668
7. Maggini J, Mirkin G, Bognanni I, Holmberg J, Piazzon IM, Nepomnaschy I, Costa H, Canones C, Raiden S, Vermeulen M, Geffner JR (2010) Mouse bone marrow-derived mesenchymal stromal cells turn activated macrophages into a regulatory-like profile. PLoS One 5:e9252
8. Spaggiari GM, Abdelrazik H, Becchetti F, Moretta L (2009) MSCs inhibit monocyte-derived DC maturation and function by selectively interfering with the generation of immature DCs: central role of MSC-derived prostaglandin E2. Blood 113:6576-6583
9. Meisel R, Brockers S, Heseler K, Degistirici Ö, Bülle H, Woite C, Stuhlsatz S, Schwippert W, Jäger M, Sorg RV, Henschler R, Seissler J, Dilloo D, Däubener W (2011) Human but not murine multipotent mesenchymal stromal cells exhibit broad-spectrum antimicrobial effector function mediated by indoleamine 2,3-dioxygenase. Leukemia 25:648-654
10. Howe DK, Sibley LD (1995) Toxoplasma gondii comprises three clonal lineages: correlation of parasite genotype with human disease. J Infect Dis 172:1561-1566
11. Lin Y, Hogan WJ (2011) Clinical application of mesenchymal stem cells in the treatment and prevention of graft-versus-host disease. Adv Hematol 2011:427863
12. Montoya JG, Liesenfeld O (2004) Toxoplasmosis. Lancet 363:1965-1976
13. Zhao Y, Ferguson DJ, Wilson DC, Howard JC, Sibley LD, Yap GS (2009) Virulent Toxoplasma gondii evade immunity-related GTPase-mediated parasite vacuole disruption within primed macrophages. J Immunol 182:3775-3781
14. Liesenfeld O, Parvanova I, Zerrahn J, Han SJ, Heinrich F, Munoz M, Kaiser F, Aebischer T, Buch T, Waisman A, Reichmann G, Utermöhlen O, von Stebut E, von Loewenich FD, Bogdan C, Specht S, Saeftel M, Hoerauf A, Mota MM, Krönen-Waisman S, Kaufmann SH, Howard JC (2011) The IFN-γ-inducible GTPase, Irga6, protects mice against Toxoplasma gondii but not against Plasmodium berghei and some other intracellular pathogens. PLoS One 6:e20568
15. Dubey JP, Schares G, Ortega-Mora LM (2007) Epidemiology and control of neosporosis and Neospora caninum. Clin Microbiol Rev 20:323-367
16. Pereira Garcia-Melo D, Regidor-Cerrillo J, Collantes-Fernandez E, Aguado-Martinez A, Del Pozo I, Minguijon E, Gomez-Bautista M, Aduriz G, Ortega-Mora LM (2010) Pathogenic characterization in mice of Neospora caninum isolates obtained from asymptomatic calves. Parasitology 137:1057-1068
17. Regidor-Cerrillo J, Gomez-Bautista M, Sodupe I, Aduriz G, Alvarez-Garcia G, Del Pozo I, Ortega-Mora LM (2011) In vitro invasion rate comprise virulence-related phenotypic traits of Neospora caninum. Vet Res 42:41
18. Degrandi D, Konermann C, Beuter-Gunia C, Kresse A, Würthner J, Kurig S, Beer S, Pfeffer K (2007) Extensive characterization of IFN-induced GTPases mGBP1 to MGBP10 involved in host defense. J Immunol 179:7729-7740
19. Sonda S, Fuchs N, Connolly B, Fernandez P, Gottstein B, Hemphill A (1998) The major 36 kDa Neospora caninum tachyzoites surface protein is closely related to the major Toxoplasma gondii surface antigen. Mol Biochem Parasit 97:97-108
20. Spekker K, Czesla M, Ince V, Heseler K, Schmidt SK, Schares G, Däubener W (2009) Indoleamine 2,3-dioxygenase is involved in defense against Neospora caninum in human and bovine cells. Infect Immun 77:4496-4501
21. Adams LB, Hibbs JB, Taintor RR, Krahenbuhl JL (1990) Microbiostatic effect of murine-activated macrophages for Toxoplasma gondii. Role for synthesis of inorganic nitrogen oxides from l-arginine. J Immunol 144:2725-2729
22. Scharton-Kersten TM, Yap G, Magram J, Sher A (1997) Inducible nitric oxide is essential for host control of persistent but not acute infection with the intracellular pathogen Toxoplasma gondii. J Exp Med 185:1261-1273
23. Könen-Waisman S, Howard JC (2007) Cell-autonomous immunity to Toxoplasma gondii in mouse and man. Microbes Infect 9:1652-1661
24. Taylor GA, Collazo CM, Yap GS, Nguyen K, Gregorio TA, Taylor LS, Eagleson B, Secrest L, Southon EA, Reid SW, Tessarollo L, Bray M, McVicar DW, Komschlies KL, Young HA, Biron CA, Sher A, Woude GF (2000) Pathogen-specific loss of host resistance in mice lacking the IFN-gamma-inducible gene IGTP. Proc Natl Acad Sci USA 97:751-757
25. Taylor GA, Feng CG, Sher A (2004) p47 GTPases: regulators of immunity to intracellular pathogens. Nat Rev Immunol 4:100-119
26. Howard JC, Hunn JP, Steinfeldt T (2011) The IRG protein-based resistance mechanism in mice and its relation to virulence in Toxoplasma gondii. Curr Opin Microbiol 14:414-421
27. Martens S, Parvanova I, Zerrahn J, Griffiths G, Schell G, Reichmann G, Howard JC (2005) Disruption of Toxoplasma gondii parasitophorous vacuoles by the mouse p57-resistance GTPases. PLoS Pathogen 3:e24
28. Steinfeld T, Könen-Waismann S, Tong L, Pawlowski N, Lamkemeyer T, Sibley LD, Hunn JP, Howard JC (2010) Phosphorylation of mouse immunity-related GTPase (IRG) resistance proteins is an evasion strategy for virulent Toxoplasma gondii. PLoS Biol 8:e1000576
29. Reid AJ, Vermont SJ, Cotton JA, Harris D, Hill-Cawthorne GA, Könen-Waisman S, Latham SM, Mourier T, Norton R, Quail MA, Sanders M, Shanmugam D, Sohal A, Wasmuth JD, Brunk B, Grigg ME, Howard JC, Parkinson J, Roos DS, Trees AJ, Berriman M, Pain A, Wastling JM (2012) Comparative genomics of the apicomplexan parasites Toxoplasma gondii and Neospora caninum. Coccidia differing in host range and transmission strategy. PLoS Pathogen 8:e1002567
30. Yamamoto M, Ma JS, Mueller C, Kamiyama N, Saiga H, Kubo E, Kimura T, Okamoto T, Okuyama M, Kayama H, Nagamune K, Takashima S, Matsuura Y, Soldati-Favre D, Takeda K (2011) ATF6beta is a host cellular target of the Toxoplasma gondii virulence factor ROP18. J Exp Med 208:1533-1546
31. Niedelman W, Gold DA, Rosowski EE, Sprokholt JK, Lim D, Farid Arenas A, Melo MB, Spooner E, Yaffe MB, Saeij JP (2012) The rhoptry proteins ROP18 and ROP5 mediate toxoplasma gondii evasion of the murine, but not the human, interferon-gamma response. PLoS Pathog 8:e1002784
32. Bekpen C, Hunn JP, Rhode C, Parvanova I, Guethlein L, Dunn DM, Glowalla E, Leptin M, Howard JC (2005) The interferon-inducible p47 (IRG) GTPases in vertebrates: loss of the cell autonomous resistance mechanism in the human lineage. Genom Biol 6:r92
33. Gorbacheva VY, Lindner D, Sen GV, Vestal DJ (2001) The interferon (IFN)-induced GTPase. mGBP2. Role in IFN-gamma-induced murine fibroblast proliferation. J Biol Chem 277:6080-6087
34. Guenzi E, Töpolt K, Lubeseder-Martellato C, Jörg A, Naschberger E, Benelli R, Albini A, Stürzel M (2003) The guanylate binding protein-1 GTPase controls the invasive and angiogenic capability of endothelial cells through inhibition of MMP-1 expression. EMBO J 22:3772-3782
35. Anderson SL, Cartpon JM, Lou J, Rubin BY (1999) Interferon-induced guanylate binding protein-1 (GBP-1) mediates an antiviral effect against vesicular stomatitis virus and encephalomyocarditis virus. Virology 256:8-14
36. Kim BH, Shenoy AR, Kumar P, Das R, Tiwari S, MacMicking JD (2011) A family of IFN-gamma-inducible 65-kD GTPases protects against bacterial infection. Science 332:717-721
37. Yamamoto M, Okuyama M, Ma JS, Kimura T, Kamiyama N, Saiga H, Ohshima J, Sasai M, Kayama H, Okamoto T, Huang DC, Soldati-Favre D, Horie K, Takeda J, Takeda K (2012) A cluster of interferon-g-inducible p65 GTPases plays a critical role in host defense against Toxoplasma gondii. Immunity 37:302-313
38. Virreira-Winter S, Niedelman W, Jensen KD, Rosowski EE, Julien L, Spooner E, Cardonna K, Burleigh BA, Saeij JPJ, Ploegh HL, Frickel EM (2011) Determinants of GBP recruitment to Toxoplasma gondii vacuoles and the parasitic factor that control it. PLoS One 6:e24434